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The 200 spring Consumer 
Scoreboard shows a clear progress 
in national consumer conditions 
in nearly all EU countries after the 
steep decline in 2009. The 200 
index reveals indeed that consumer 
conditions have rebounded after 
the sharp fall in 2009, with most 
countries matching or exceeding 
2008 levels.
The e-commerce gap, major 
issue highlighted by the 
Scoreboard
The Scoreboard confirms a growing 
gap between domestic and cross-
border e-commerce, despite a clear 
potential of cross-border purchases 
in terms of choice and savings. But 
the study suggests that consumers 
are much more confident in cross-
border shopping once they have 
tried it. Consumers’ perceptions 
seem thus to be a major barrier 
to cross-border shopping on the 
internet.
The Scoreboard shows continued 
growth of domestic e-commerce, 
The 5th EU Consumer Scoreboard 
was presented on  March by 
the European Commissioner for 
Health and Consumer Policy, John 
Dalli, at the European Consumers’ 
Organisation (BEUC)’s premises. The 
biannual Scoreboard report is the 
statistical evidence of how markets 
are delivering to consumers both at 
EU and at national level.
BEUC and Commissioner Dalli 
commit to further collaboration to 
protect European consumers
What’s the Scoreboard?
The biannual Consumer Scoreboard 
is the statistical evidence report 
of how markets are delivering 
to consumers both at EU and at 
national level, on basis of various 
performance indicators. The 
Scoreboard provides figures and 
alerts about how the single market 
is performing for EU consumers 
in terms of choice, prices and 
satisfaction. 
The spring edition (“Consumer 
Conditions Scoreboard”) looks 
in particular at the integration 
of the retail market and national 
conditions for consumers, measured 
by the Annual Index of Consumer 
Conditions. This index is defined 
by factors such as the effectiveness 
of resolving disputes and handling 
complaints, the quality of 
regulations and consumer trust in 
authorities, retailers, advertisers 
and consumer organisations.
The Scoreboard data are based on 
surveys of consumers and retailers, 
as well as on statistical data such as 
income levels.
The EU Commissioner John Dalli with 
BEUC Director General Monique Goyens
2Health Programme: 20 Work Plan 
and calls for proposals published
The 20 Work Plan for 20 for the 
implementation of the 2008-203 Public 
Health Programme was published on 03 
March. At the same time, the Executive 
Agency for Health and Consumers (EAHC) 
published calls for proposals for projects, 
operating grants, conferences and joint 
actions in the field of public health for 
20.
The 20 Work Plan gives more emphasis 
and resources to a focused cooperation 
with the Member States. The amount 
of 7,040,000€ will be dedicated to 
the funding of five joint actions. In 
comparison to 200, the total indicative 
amount available for operating grants 
for non-governmental organisations or 
specialized networks active in the field 
of Public Health has increased and is now 
4,000,000€. 
The indicative amount for the call for 
proposals for projects is 4,650,000€. 
This call for proposals is seeking for very 
specific projects in seven different areas, 
where only one project per call will be 
funded; exception will be made for the 
rare disease networks. Funds for 800,000€ 
will also be made available for grants for 
conferences.
The deadline for submission of proposals 
is 27 May 20.
Further information is available at:
http://ec.europa.eu/health/programme/
how_does_it_work/call_for_proposals/
index_en.htm
and
http://ec.europa.eu/eahc/index.html
The 20 Work Plan is available at:
http://ec.europa.eu/health/programme/
docs/wp20_en.pdf
In brief
(CPC) network, which brings 
together national enforcers, and 
the European Consumer Centres, 
which provide free help and advice 
to consumers shopping in the Single 
Market.
Monique Goyens, BEUC Director 
General, commented the figures 
as follows: “Green shoots of rising 
consumer confidence are evident 
in the findings, but there are some 
alarming signs of how well informed 
European businesses are of their 
obligations to consumers and there 
is strong proof that countries with 
low consumer confidence levels 
often are a result of unambitious 
consumer policy, a lack of market 
supervision and weak enforcement 
of consumer rights”.
Commissioner John Dalli declared: “It 
is good news that consumers’ worries 
about cross-border shopping tend 
to evaporate once they’ve actually 
tried it and had a good experience. 
But the results also confirm how 
much work there is still ahead of 
us in dismantling the remaining 
barriers to the benefit of European 
economy and European consumers 
and businesses alike”.
with 36% of EU consumers having 
shopped online from national sellers 
in 200 (34% in 2009). However, 
cross-border e-commerce continues 
to grow at a sluggish pace (9% in 
200, compared with 8% in 2009), 
despite clear benefits in terms of 
savings and choice as evidenced in 
earlier studies.
However, these concerns are much 
less widespread among consumers 
who have actually shopped 
cross-border (34%, 30% and 20% 
respectively).
The findings suggest a key role 
for more effective information 
about existing cross-border 
advice, enforcement and redress 
mechanisms. These include the 
Consumer Protection Co-operation 
zoonoses, published on 22 March by 
the European Food Safety Authority 
(EFSA) and the European Centre 
for Disease Prevention and Control 
(ECDC).
Human salmonellosis cases were 
reduced almost by half over a five-
year period, thanks to measures 
introduced by the European Union. 
This encouraging figure emerges 
from the 2009 EU summary report on 
Salmonella cases cut to half thanks 
to EU measures
The full text of the Scoreboard is available at:
http://ec.europa.eu/consumers/strategy/facts_
en.htm#5CMS
Among consumers who have 
not made a cross-border distance 
purchase:
• 62% are worried about fraud and 
scams; 
• 59% cite concerns about what to 
do when problems arise; 
• 49% are put off by expected 
delivery problems.
Cross-border e-commerce appears 
to be at least as reliable as domestic 
e-commerce or even more: 
•only 6% of cross-border purchases 
were delayed (8% for domestic 
purchases); 
• the product did not arrive in 5% of 
cross-border cases (6% for domestic 
purchases).
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Pharmaceuticals: the EU Register of 
Clinical Trials is now online
From 22 March, all EU citizens will have 
access to information on the thousands 
of authorised pharmaceutical clinical 
trials that are underway in the EU. The aim 
of this official public register is to make 
clinical research on pharmaceuticals 
more transparent for patients and others 
and to avoid unnecessary duplication of 
clinical trials.
Clinical trials are investigations in humans 
intended to discover or verify the effects 
of one or more investigational medicinal 
products. 
The aim of a clinical trial is not necessarily 
to apply for a future marketing 
authorisation. Clinical trials can indeed be 
conducted also for studies on authorised 
medicines – for example, in the case of 
comparison between two authorised 
medicines. 
Every year approximately 4,000 clinical 
trials are authorised in the EU. Since most 
of them last 2 to 3 years, this means that 
around 0,000 trials are ongoing at any 
given time. 
Clinical trials performed in the EU must 
be conducted in accordance with the EU 
Clinical Trials Directive (200/20/EC) and 
its implementing legislation, which aims 
at ensuring a high level of protection of 
patient safety, as well as reliability of the 
data generated in a trial.
The Clinical Trials register contains 
information about clinical trials 
authorised in the EU, whether they take 
place in one Member State or several. It 
includes clinical trials conducted by both 
industry and research institutions. The 
information is rendered public once the 
clinical trial has been authorised. 
The European Medicines Agency 
(EMA) is responsible for the day-to-day 
management of the online register. 
The sponsor of the clinical trial (the 
responsible party for the trial) provides 
and updates the information in the 
register via the national competent 
authority of the country, or countries, 
in which it is being conducted. The 
register is part of the overarching EU 
public database EudraPharm, which also 
centralizes information on medicines 
authorised by the EU. 
The clinical trials register is available at:
http://www.ClinicalTrialsRegister.eu
In brief
The members of the European 
Commission’s Platform for Action 
on Diet, Physical Activity and 
Health - European-level umbrella 
organisations ranging from the food 
industry, health organisations and 
other civil society NGOs – recently 
agreed to step up action to tackle the 
growing problem of overweight and 
obesity related health problems.
Obesity is a growing problem in 
the EU: according to the “Health 
at a Glance: Europe 200” report, 
published last December by the 
European Commission and the 
OECD, the rate of obesity has more 
than doubled in the past 20 years 
in most EU Member States. The 
prevalence varies from country 
to country, from less than 0% to 
over 20% some Member States. On 
average, an estimated 5% of the EU 
adult population is obese. 
Currently,  in 7 children in the EU are 
overweight or obese – and it is likely 
that the figures will rise even further. 
This is worrying, as children who 
are obese or overweight are more 
likely to suffer from certain chronic 
Disease prevention: stakeholders 
renew their commitment to 
combat obesity
Human salmonellosis cases were 
reduced from 96,000 cases in 
2004 to 08,000 cases in 2009. This 
success story dates back to 2003, 
when the European Parliament and 
the Council adopted a Regulation 
(EC 260/2003) and a Directive 
(EC 99/2003) which started the 
implementation of enhanced 
Salmonella control programmes in 
all Member States.
Thanks to the measures foreseen by 
the legislation, targets for reduction 
of Salmonella in flocks of poultry 
(laying hens, broilers, turkeys) were 
set, stricter hygiene standards in 
slaughterhouses were introduced, 
control programmes were 
inaugurated by Member States and 
restrictions on the trade of products 
from infected flocks were imposed.
From 2005 onwards, the European 
Food Safety Authority (EFSA), in 
collaboration with the European 
Centre for Disease Prevention and 
Control (ECDC), has been entrusted 
to prepare a yearly EU summary 
concerning monitoring of zoonoses. 
The EU reports are based on annual 
reports submitted by the Member 
States and Norway and they contain a 
valuable overview of the prevalence 
of zoonoses in the EU.
Health and Consumer Policy 
Commissioner John Dalli declared: 
“The EU has made great strides in 
its battle against Salmonella and 
the consistent fall in the number 
of cases is testament to the strong, 
comprehensive EU measures put 
in place to tackle this disease. 
The Commission has at no point 
stopped monitoring or reacting to 
the challenge of Salmonella and the 
current EFSA/ECDC report clearly 
illustrates the improved situation 
and positive developments. Rest 
assured, however, that the fight 
against zoonotic agents will continue 
relentlessly always aiming to further 
reduce their incidence”.
Further information is available at:
http://ec.europa.eu/food/food/biosafety/salmonella/
index_en.htm
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Reducing EU health inequalities
On 8 March the European Parliament 
adopted a resolution on “Reducing 
health inequalities in the EU”. The text 
was issued by the EP Committee on the 
Environment, Public Health and Food 
Safety (Rapporteur MEP Edite Estrela).
Health and life expectancy are still very 
much linked to social circumstances, and 
major inequalities also exist between 
countries and regions. For example, life 
expectancy among men aged 65 varied 
across Member States in 2007, from a 
high of 8.4 years in France to a low of 
2.8 years in Latvia. The range for women 
was slightly greater, from 23.0 years in 
France to 6.4 years in Bulgaria (source: 
Eurostat, 200).
The reasons for these differences in 
health are, in many cases, avoidable and 
unjust, because they are a consequence 
of differences in opportunities, in access 
to services and material resources.
In the text of the resolution, the European 
Parliament welcomes the key suggestions 
made by the European Commission in its 
Communication entitled “Solidarity in 
health: reducing health inequalities in 
the EU”, namely:
- making a more equitable distribution 
of health part of the EU overall goals for 
social and economic development;
- improving knowledge and data bases;
- building commitment across society for 
reducing health inequalities;
- meeting the needs of vulnerable 
groups;
- developing the contribution of EU 
policies to the reduction of health 
inequalities.
According to the EP resolution, the 
reduction of health inequalities must 
be considered an essential priority at 
all levels of policy making, pursuing a 
Health in All Policies Approach (HiAP) and 
ensuring effective impact assessments.
The adopted resolution is available at:
http://www.europarl.europa.eu/
EP news
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On 4 March the European 
Commission launched a consultation 
to gather stakeholders’ views on 
possible actions that can protect 
EU citizens more effectively against 
serious cross-border health threats. 
The consultation includes questions 
on preparedness planning, risk 
assessment, management of health 
threats and on how to better 
communicate with citizens and 
professional groups.
The aim of this consultation is to seek 
the views of stakeholders on what 
action the European Commission 
should take to protect EU citizens 
more effectively against serious 
cross-border health threats. The 
Commission’s initiative on health 
security in the EU comes at the 
request of the European Council, 
following its conclusions of 3 
September 200, on lessons learned 
from the A/HN Pandemic and 
Health Security in the EU.
Even though legislation on EU action 
on the prevention and control of 
infectious diseases exists since 
998, this legislation does not cover 
indeed cross-border health threats 
other than infectious diseases. The 
aim of this initiative is therefore to 
consider the possibility and need to 
ensure that all types of public health 
threats are addressed in a similar way 
to infectious diseases.
National, regional and local 
authorities, health institutions, 
NGO’s, interest groups, enterprises 
and individual stakeholders are 
welcome to provide comments to 
this consultation.
The results of this web-based 
consultation will be published a few 
weeks after its closure under the 
form of a short factual report on the 
consultation.
All interested parties are invited to 
submit their comments by 29 April 
20.
Consultation on health security: 
how can EU citizens be better 
protected?
The consultation paper and online questionnaire are 
available at:
http://ec.europa.eu/health/preparedness_response/
consultations/preparedness_cons_02_en.htm
diseases later in life.
In such a frame, the members of the 
European Commission’s Platform 
for Action on Diet, Physical Activity 
and Health decided to commit to 
boosting activities that contribute 
to the objectives of the Strategy for 
Europe on Nutrition, Overweight 
and Obesity related health issues 
by 203. Priorities focus on children 
and how to make healthy choices 
available whilst also encouraging 
physical activity and sports. Action 
will target vulnerable groups, 
including children and adolescents 
and low socio-economic groups.
 The need to improve existing 
actions in product composition for 
healthier food and in advertising 
and marketing to children was also 
highlighted by the members of the 
Platform.
The European Commissioner for 
Health and Consumer Policy, John 
Dalli, commented: “I am pleased to 
see that Platform members have 
agreed to scale up their action. This 
demonstrates commitment to the 
goals we set out together to fight 
the increasing trend of obesity, to 
address poor dietary habits and to 
increase physical activity levels in 
the EU”.
Further information is available at:
http://ec.europa.eu/health/nutrition_physical_activ-
ity/platform/index_en.htm
